Come up with a name for your new list and we'll add to it:
AnaptysBio raised a round of funding on October 17, 2009. Investors include
Qualifying Therapeutic Discovery Project.
AnaptysBio is a privately-held company focused on the generation of antibody therapeutics and is the leader in the use of somatic hypermutation (SHM) for antibody discovery and optimization. The compa…